NICE fast-tracks epilepsy recommendation
Doctors are now able to prescribe Epidyolex with clobazam – a seizure-preventing cannabis-based treatment – to eligible people, including children, with the severe epilepsy types Lennox Gastaut syndrome and Dravet syndrome.
Following an agreement between NHS England agreement and GW Pharma, the National Institute for Health and Care Excellence (NICE) has been able to recommend the treatment, with access fast tracked and available from January 6.
Clinical trials have shown the treatment could reduce the number of seizures by up to 40 per cent in some children when used in combination with clobazam.
“Living with or caring for someone with severe epilepsy is exceptionally challenging, especially as there are so few treatments available for the rare forms of the condition,” said Simon Stevens, NHS chief executive. “Thousands of people, including children, will now have access to this treatment, which has the potential to make a real difference.”
Understand the important role oral rehydration products play in helping prevent dehydration after illness
Discover the key benefits of different types of laxatives, and the right questions to ask customers to ensure you know which to recommend
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
DHSC increases PPE order limit by 25% over Christmas
The DHSC has increased its PPE order limit by 25 per cent over Christmas.
1 Min Article
Treating acid reflux and heartburn in the pharmacy
Understand how omeprazole 20mg works to treat heartburn and acid reflux symptoms
2 Min Module